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Incorporation of noncanonical amino acids into cellular proteins
often requires engineering new aminoacyl-tRNA synthetase activ-
ity into the cell. A screening strategy that relies on cell-surface
display of reactive amino acid side-chains was used to identify a
diverse set of methionyl-tRNA synthetase (MetRS) mutants that
allow efficient incorporation of the methionine (Met) analog azi-
donorleucine (Anl). We demonstrate that the extent of cell-surface
labeling in vivo is a good indicator of the rate of Anl activation by
the MetRS variant harbored by the cell. By screening at low Anl
concentrations in Met-supplemented media, MetRS variants with
improved activities toward Anl and better discrimination against
Met were identified.
click chemistry  high-throughput screening  protein engineering
Amino acids that carry noncanonical side-chains have be-come useful tools for protein engineering and analysis.
Their uses include stabilization of protein–protein interfaces
(1–3), modification of spectral properties of proteins (4, 5), and
determination of three-dimensional protein structure (6–8). The
value and versatility of noncanonical amino acids has been
increased significantly by their recent use in conjugation (9, 10),
detection (11, 12), and selective isolation (13) of proteins.
Among the reactive groups introduced into biological molecules,
azides are especially useful (14). Azides can be ligated under
physiological conditions to phosphines through the Staudinger
ligation or to terminal alkynes through Cu(I)-catalyzed [3  2]
azide-alkyne cycloaddition, both in bioorthogonal fashion. Tak-
ing advantage of the bioorthogonality of these reactions, azides
have been used to selectively label a diverse set of biomolecules
including proteins (15), glycans (16), and lipids (17, 18).
Azide functionality can be introduced into proteins in vivo
through use of the methionine (Met) surrogate, azidohomoala-
nine (Aha) (15, 19). Because Aha is activated by the wild-type
MetRS (15), it enables convenient cotranslational labeling of
proteins in vivo. Dieterich and coworkers recently reported the
identification of newly synthesized proteins in mammalian cells
through pulse-labeling with Aha (13). In this method, called
bioorthogonal noncanonical amino acid tagging (BONCAT),
azide-bearing proteins synthesized during the Aha pulse were
separated from the pool of preexisting proteins in the cell
through a Cu(I)-catalyzed ligation to an alkyne-derivatized
biotin tag and subsequent affinity chromatography.
Although Aha is ideal for identification of newly synthesized
proteins in cultures containing a single cell type, it is not suitable
for directing protein labeling to specific cell types in complex
cellular mixtures (e.g., in microbial communities, in tissues or in
intact animals) because MetRS is common to all cells. However,
we have recently shown that cell-selective metabolic labeling can
be achieved by using azidonorleucine (Anl, 2) (Fig. 1A), rather
than Aha as the Met surrogate (20). Unlike Aha, Anl is not
activated efficiently by any of the wild-type aminoacyl-tRNA
synthetases (aaRS), and Anl labeling can be restricted to cells
outfitted with mutant forms of MetRS. Link and coworkers
recently reported a high-throughput screen for E. coli MetRS
mutants that activate Anl (21). Cells carrying such mutants
display Anl residues on their surfaces, and can be identified and
isolated by fluorescence-activated cell sorting (FACS; Fig. 1B).
Although the clones isolated in this way showed only modest
levels of Anl incorporation into marker proteins, analysis of the
isolated MetRS mutants (all of which shared a Leu-to-Gly
mutation at position 13) led to the preparation of the single-site
L13G variant (MetRS-L13G). MetRS-L13G allows near-
complete replacement of Met by Anl.
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Fig. 1. Reagents and screening method used in this study. (A) Amino acids
and tagging reagents: 1,Met; 2,Anl; 3, biotin-PEO-cyclooctyne. (B) Scheme for
the library screen for identification of MetRS mutants that allow Anl incor-
poration into cellular proteins.
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Here, we report screening methods that yield MetRS mutants
with greatly enhanced activity toward Anl and improved dis-
crimination against Met. We describe the selection and charac-
terization of these MetRS variants, and discuss the factors that
we believe to be most important in their selection. Several of the
mutants reported here are superior toMetRS-L13Gwith respect
to metabolic protein labeling with Anl in media supplemented
with Met.
Results and Discussion
Link and coworkers randomized four positions (L13, P257,
Y260, and H301) in the Met-binding pocket of E. coli MetRS
(21) (Fig. 2). Screening of the resulting library for in vivo
incorporation of Anl into proteins yielded threeMetRSmutants:
L13G-P257L-Y260T-H301A, L13G-P257S-Y260T-H301L, and
L13G-P257L-Y260L-H301V, but not L13G. We wondered
whether L13G failed to emerge from the screen because of
incomplete (62%) library coverage, or because of other aspects
of our experimental design that might have precluded isolation
of highly active mutants. To ensure complete coverage of the
saturation mutagenesis library, we created a library of lower
diversity by reducing the number of randomized sites from four
to three, while increasing the number of clones that carry the
library by optimizing ligation and transformation conditions.
Examination of the crystal structure ofMet-boundE. coliMetRS
(22) reveals that the sulfur atom of Met is recognized through
hydrogen bonds with O of Y260 and the backbone amide of
L13. (Fig. 2) H301 is also implicated in recognition of the sulfur
atom (23). Positions 13, 260, and 301 were therefore selected for
randomization. The resulting library is a subset of that screened
by Link and coworkers, and includes the L13G mutant. Triple
mutants isolated from this library were named according to the
single-letter code for each mutation they carry (e.g., the MetRS
variant carrying the L13G, Y260M, and H301L mutations is
designated ‘‘GML’’).
The library was constructed through PCR gene assembly using
primers containing degenerate NNK (N  A, C, G, T; K  G,
T) codons at residues 13, 260, and 301. The assembled fragments
were ligated into plasmid pAJL-20 (24), and the resulting library
was transformed into M15MA (19). The number of independent
clones was maintained 107 for every transformation step. The
library coverage was estimated to be 99.9% using the program
GLUE (25), which assumes an unbiased library where each
member is equally likely to occur.
OmpC Expression and Cell-Surface Labeling with Anl. pAJL-20 di-
rects the synthesis of an E. coli OmpC variant carrying six
surface-exposed Met residues under control of the isopropyl--
thiogalactoside (IPTG)-inducible T5 promoter (21). Synthesis of
Anl-bearing OmpC was performed in Met-auxotrophic M15MA
cells transformed with variants of pAJL-20 carrying MetRS
mutants. Minimal medium supplemented with all 20 canonical
amino acids was inoculated with an aliquot of transformants and
grown to OD600  1.0. Cells were washed and shifted into
minimal medium lacking Met, but supplemented with Anl.
OmpC expression was initiated by addition of IPTG. The azide
groups displayed on the surfaces of the resulting cells were
ligated to biotin-PEO-cyclooctyne (3) (Fig. 1A) and labeled with
avidin conjugated to Alexa Fluor 488.
The screen outlined in Fig. 1B uses the extent of fluorescence
labeling as a reporter for Anl incorporation, and in turn, for
MetRS activity toward Anl; the highest levels of OmpC expres-
sion and fluorescence labeling are expected in cells carrying the
MetRS mutants most active toward Anl. However, over-
production of membrane proteins such as OmpC can have
adverse effects on cell viability (26, 27); efficient synthesis of
OmpC may place the most active clones at a disadvantage in the
screen. To determine the extent to which OmpC expression
affects cell viability and labeling efficiency, OmpC was induced
at 1 mM Anl in M15MA cells carrying MetRS-L13G, and
changes in cell-surface labeling and cell viability were monitored
for 4 h. Significant losses of viable cells were observed over this
period (Fig. S1A), but fluorescence labeling was nearly complete
after only 30min of induction (Fig. S1B). Tominimize the effects
of OmpC toxicity while maintaining high fluorescence levels,
OmpC expression was limited to 30–40 min in all subsequent
experiments.
Screening and Identification of Active MetRS Mutants. Near-
complete replacement of Met by Anl was shown in M15MA cells
carrying MetRS-L13G when protein synthesis was induced in
Met-free minimal medium supplemented with 1.0 mM Anl (21).
In a first step toward isolation of MetRS variants that exceed the
activity of L13G, M15MA cells carrying the naïve three-position
library (Fig. 3A) were screened under similar conditions. Ex-
pression of OmpC was induced at 1.0 mM Anl in minimal
medium lacking Met, and Anl residues displayed on the cell
surface were fluorescently labeled. The top 1% of fluorescent
clones were isolated by FACS and regrown in rich medium for
a second round of screening. After a single round of screening,
f luorescent clones constituted 65% of the sorted cells. After two
rounds of screening, individual clones from the resulting popu-
lation (Fig. 3B) were sampled. Although the identified clones
revealed a highly diverse set of sequences, all clones exhibited
high levels of labeling at 1.0 mMAnl.Within this set, fourMetRS
mutants (GML, GIL, GCL, and PNL) yielded the highest levels
of f luorescence.
To identify mutants that can sustain protein synthesis at lower
Anl concentrations, the naïve library was screened at 0.3 mM
Anl. In addition to increasing the stringency of the screen, a
lower Anl concentration further limits OmpC synthesis and the
associated toxicity. In two rounds of screening, the top 0.6% of
the labeled clones were sorted, and individual clones were
identified from the resulting population. (Fig. 3C) The NLL
mutant appeared in 50% of the clones sampled. Analysis of
isolated clones by FACS identified NLL and three other mutants
(SLL, CLL, and PIL) that yield the highest f luorescence levels.
Further reduction of the Anl concentration to 0.1 mM resulted
in enrichment of clones carrying the NLL, SLL, PLL, and PLI
Fig. 2. Residues surrounding the ligand side-chain in the amino acid binding
pocket of the wild-type E. coli MetRS. The ligand is displayed in yellow,
whereas residues considered for saturation mutagenesis are shown in green.
Underlined residues were selected for randomization in this study. The hy-
drogen-bonding network that recognizes the sulfur atom on the ligand is
highlighted by yellow lines. An enzyme-boundwatermolecule (labeled HOH)
also participates in this network. Figure was generated using PyMOL (v1.0,
DeLano Scientific) based on coordinates from the Protein Data Bank (PDB ID:
1F4L) (22).
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mutants. (Fig. 3D) Since clones carrying the NLL mutant
represent the dominant products of both screens, we concluded
that the screen had converged to a solution.
Residue-specific incorporation of noncanonical amino acids
into recombinant proteins is often carried out under conditions
that minimize the intracellular concentration of the canonical
amino acid to be replaced (28, 29). However, for applications
that require the use of nonauxotrophic cells and/or rich media,
it is necessary to engineer aaRS that discriminate against their
natural substrates. To identify such mutants, the naïve library
was screened against Met for three rounds at 1.0 mM Anl, with
increasing concentrations of Met (0.01, 0.03, and 0.1 mM) added
to themedium in successive rounds. The final population showed
only limited sensitivity to Met, and exhibited substantial labeling
even when Met and Anl were both supplied at concentrations of
1.0 mM (Fig. 3E). The NLL and PLL mutants were highly
enriched by this screen.
Characterization ofMetRSMutants in Vivo.Although theNLL, SLL,
and PLL mutants emerged from higher stringency screens, these
mutants appear to be absent from the population isolated from
the 1.0 mMAnl screen. To understand why highly active mutants
were not identified through screens of lower stringency, we
compared the extent of fluorescence labeling, at Anl concen-
trations varying between 0.03 and 3.0 mM, of clones isolated
from the 1.0 mM Anl (GML, GIL, GCL, and PNL) and 0.3 mM
Anl (NLL, CLL, SLL, and PIL) screens. The median values of
the fluorescence from labeled cell populations were determined
by flow cytometry. The dose-response data were fit to the Hill
equation, and an EC50 value was determined for each MetRS
mutant (Table S1, Fig. 4A, and Fig. S2). We found similar
labeling levels for all eight mutants at 1.0 mMAnl, but only those
clones isolated from the more stringent screen maintained high
fluorescence levels at 0.3 mM Anl. The absence of highly active
mutants such as NLL from the population selected at 1.0 mM
Anl might be due simply to undersampling, but increased OmpC
expression and toxicity resulting from faster Anl activationmight
also have hindered the identification of highly active mutants in
this screen.
To determine how well the isolated MetRS mutants support
protein synthesis inMet-depletedmedia supplemented with Anl,
they were transferred to plasmid pAJL-61, which encodes a
6His-tagged murine dihydrofolate reductase (mDHFR) under
control of the IPTG-inducible T5 promoter (21). The resulting
plasmids were transformed intoM15MA, and protein expression
was induced for 3.5 h in minimal media supplemented with 0.1,
0.3, or 1.0 mMAnl, 0.3 mMMet, or no 20th amino acid. mDHFR
was purified from cell lysates by Ni-NTA chromatography, and
tryptic fragments from purified proteins were analyzed by
MALDI-MS. Analysis of whole-cell lysates by SDS/PAGE re-
vealed a pattern of mDHFR expression levels consistent with
those inferred from cell-surface fluorescence, as described
above: All eight mutants supported similar levels of mDHFR
expression at 1.0 mM Anl, but only those mutants isolated from
the 0.3 mM Anl screen sustained similar levels of expression at
0.3 mM Anl (Fig. 4B and Fig. S3). Similarly, MALDI-MS
analysis of tryptic peptides indicated near-complete replacement
of Met by Anl by all eight mutants at 1.0 mM Anl, whereas
complete replacement at 0.3 mM Anl was observed only for
mutants isolated from the 0.3 mM Anl screen (Fig. S4).
Determination of Activation Kinetics in Vitro.MetRS mutants were
expressed and purified for determination of Anl activation
kinetics in vitro (Table 1). In our experience, the relative rates
of activation of noncanonical amino acids measured in vitro
correlate well with their efficiencies of incorporation in vivo (15,
30). As expected, we observed faster activation of Anl by
mutants isolated through screens performed at lower concen-
trations of Anl (Fig. 4C). Cell-surface display is a good predictor
of MetRS activity.
Clones carrying the NLL and PLL mutants exhibited fluores-
cence labeling in screens performed in Met-supplemented me-
dia. The rates of activation of Met by NLL, PLL, and two similar
mutants (SLL and CLL, both obtained from the noncompetitive
high-stringency screen) were determined and their substrate
preferences compared. Only the NLL and PLL mutants activate
Anl faster than Met (Table 1); only the competitive screen
yielded mutants that prefer the noncanonical substrate. The
results of competitive screens depend directly on the relative
Fig. 3. Fluorescence histograms of the naïve library and populations en-
riched in fluorescent clones. The naïve library (A) is shown labeled at 1.0 mM
Anl. Populations enriched through two rounds of screening at 1.0mMAnl (B),
0.3 mM Anl (C), or 0.1 mM Anl (D) are displayed next to MetRS mutants
identifiedby these screens. TheAnlMet screenwas performedat 1.0mMAnl
over three rounds, increasing theMet concentration from0.01mMto0.03mM
to 0.1 mM. The final population from this screen (E) is shown after labeling at
equal concentrations (1.0 mM) of Anl and Met.
Table 1. Kinetic parameters for the activation of Anl and Met by
the MetRS variants identified in this study and the L13G mutant
MetRS
Anl activation
kcat/Km,
M1 s1
Met activation
kcat/Km,
M1 s1 Selectivity*
wt† - 550,000 -
L13G 170  40 5,600  1,500 0.03
PLL 650  150 200  50 3.2
NLL 410  80 350  70 1.2
SLL 220  20 900  80 0.24
CLL 520  120 7,100  600 0.07
PLI 410  140 - -
PIL 130  40 - -
PNL 98  37 - -
GML 47  13 - -
GIL 14  3 - -
GCL 11  2 - -
Individual kcat andKmvalues for theactivationofMetandAnlarepresented
with EC50 values for cell-surface labeling in Table S1.
*Selectivity is defined as the ratio of kcat/Km for Anl to that for Met.
†Activation parameters for wild-type MetRS are taken from ref. 30.
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rates of activation of Anl and Met by each clone. In contrast,
noncompetitive screens are insensitive to the rates of activation
of Met, and can yield clones in which Anl is activated rapidly yet
cannot compete with the natural substrate.
Comparison of MetRS-L13G and Selected MetRS Mutants. We pre-
viously reported comparable specificity constants (kcat/Km) for
activation of Anl and Met by MetRS-L13G (21). Careful
reexamination of the activation kinetics suggests that our
earlier conclusions were incorrect, and that MetRS-L13G
exhibits a strong preference for Met (Table 1). Consistent with
these observations, f luorescence labeling of cells harboring the
L13G mutant shows significant sensitivity to the addition of
Met to the expression medium; f luorescence labeling is not
detected above a Met concentration of 0.03 mM (Fig. 5). In
contrast, cells bearing MetRS-NLL show much lower sensi-
tivity to the presence of Met in the medium and produce a
distinct f luorescent population even when Anl and Met are
both provided at 1.0 mM, in agreement with the activation
kinetics obtained for the NLL mutant. Furthermore, while the
incorporation of a natural amino acid was detected when Anl
was presented to cells bearing the L13G mutant at low
concentrations in Met-free medium, MetRS-NLL supports
only minimal levels protein synthesis under similar conditions
(Fig. 4B and Fig. S4). These results suggest that mutants such
as NLL and PLL may be suitable for in vivo labeling applica-
tions at physiological amino acid concentrations.
Significance of Selected Mutations. We identified 41 different
MetRS mutants that allow Anl incorporation in Met-depleted
media supplemented with 1.0 mM Anl (Table S2). Examination
of the distribution of mutations across the randomized sites
shows strong selection for Leu and other aliphatic side-chains at
position 301, and a diverse set of mutations at positions 13 and
260 (Fig. S5A). In mutants isolated from screens of higher
stringency (0.3 mM Anl or lower; 13 mutants), positions 13 and
260 are dominated by Pro and Leu, respectively (Fig. S5B).
Alternatives to Leu at position 260 are mostly hydrophobic,
whereas position 13 is commonly mutated to small and/or polar
residues and to Pro. Although the L13P mutation is unique in
eliminating the backbone hydrogen bond to the native ligand,
small and/or polar mutations might have a role in modulating
solvation, and thus the availability of the backbone hydrogen
bond to Met at this site. The overall result of these mutations is
the elimination of hydrophilic contacts to the Met side-chain,
Fig. 4. Comparison of in vivo and in vitro activities of the identifiedMetRS mutants. Data shown for mutants identified by screens at 1.0 mM and 0.3 mMAnl,
and the L13G mutant are marked in green, blue, and red, respectively. Protein expression, cell-surface labeling in vivo and Anl activation in vitro are consistent
in indicating better activity for mutants screened at lower Anl concentrations. (A) EC50 values describing the fluorescence response to Anl availability in the
expression media. (B) SDS/PAGE analysis of whole-cell lysates for cells expressing mDHFR under different conditions. Cells grown to midlog phase in medium
containing all 20 canonical amino acids were then shifted into 19-amino acid medium (no Met) supplemented with 0.1, 0.3, or 1.0 mM Anl (lanes 3, 4, and 5,
respectively), 40mg/LMet (lane6), or no20thaminoacid (lane2) before inductionofmDHFR synthesis. Lane1 shows cells before induction. For clear presentation
images were resized and lanes on the GML panel were reordered. Original images can be found in Fig. S3. (C) Specificity constants (kcat/Km) for Anl activation
measured in vitro. Average of three measurements is reported with errors bars indicating one standard deviation. Data for mutants identified by the 0.1 mM
Anl screen (PLL and PLI) are shown in dark blue.
Fig. 5. Cell-surface labeling in the presence of Met. Labeling levels were
evaluated for cells carrying the L13G and NLL mutants after OmpC expression
at 1.0 mM Anl and varying concentrations of Met. Fluorescence histograms
show that the NLLmutant is less susceptible than L13G to the presence ofMet
in the medium, in agreement with substrate preferences of these mutants
determined in vitro (Table 1).
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thereby reducing competition with Met and polar amino acids
and creating a hydrophobic pocket for Anl.
A survey of small molecule crystal structures indicates that
organic azides rarely participate in hydrogen bonds, in some
cases forming weak hydrogen bonds through the terminal nitro-
gen (31). The high-resolution (1.5 Å) X-ray crystal structures of
free and Anl-bound MetRS-SLL reveal that such a hydrogen
bond facilitates Anl binding. The terminal azide on the ligand is
recognized by an enzyme-bound water molecule, which is well
conserved in wild-type MetRS (22, 32) (HOH) (Fig. 2). More-
over, the SLL mutant does not exhibit the ligand-induced
conformational change that leads to formation of a ‘‘closed’’
binding pocket around the ligand observed in the wild-type
enzyme (22). Instead, the SLL mutant is locked in the ‘‘closed’’
conformation even in the absence of ligand. The crystal structure
shows the orientation of the L301 side-chain to be incompatible
with the ‘‘open’’ conformation of F300 (22), and suggests that
formation of the closed pocket before Anl binding might lead to
faster Anl activation and contribute to the strong bias for the
H301L mutation observed in the screens.
Most selected mutations remove from the binding site the
hydrophilic elements that ensure specificity toward Met, but do
not introduce specific contacts for Anl recognition. Such sub-
stitutions might create enzymes that are relatively indiscriminant
with respect to hydrophobic ligands. Recently, a leucyl-tRNA
synthetase variant evolved for incorporation of 2-amino-6-
(methylthio)hexanoic acid was reported to show promiscuity
toward other long-chain hydrophobic ligands (33). Similarly, the
SLL mutant discussed above was identified by library screening
to enable incorporation of 6,6,6-trif luoronorleucine into recom-
binant proteins (34). Thus, the mutants discovered in this study
may permit incorporation of other long-chain hydrophobic
ligands, or may be used as design platforms for incorporation of
longer side-chains.
Conclusions
We have successfully identified a diverse set of MetRS mutants
that enable efficient in vivo incorporation of the azide-bearing
amino acid Anl into proteins, by using a fast, high-throughput
screening strategy based on cell-surface display of reactive
side-chains. Through characterization of identified mutants, we
established in vivo fluorescence labeling of displayed azides as an
accurate predictor of both protein synthesis levels in vivo and
Anl activation rates in vitro. The results of the library screens
point to the importance of the H301L mutation, and structural
analysis of MetRS-SLL mutant suggests a role for this mutation
in locking the enzyme in the closed conformation.
Despite the small size of the library explored, we were
successful in shifting the specificity of MetRS in favor of the
unnatural ligand through screens against the natural substrate.
The identified MetRS variants provide faster activation of Anl
and significantly lower sensitivity to Met than any previously
knownmutant. These properties are essential for the use of these
enzymes in proteome-wide labeling of live cells in complex
environments.
Materials and Methods
Chemical Reagents. Anl (2) (24) was a gift from A. J. Link and M. B. van Eldijk
(California Institute of Technology, Pasadena, CA), and biotin-PEO-
cyclooctyne (3) (35) was a gift from J. D. Fisk (California Institute of Technol-
ogy, Pasadena, CA).
Plasmids, Cell Strains, and Cloning Reagents. All restriction enzymes and T4
DNA ligase were purchased from New England Biolabs. PfuUltra HighFidelity
polymerase (Stratagene) was used in all PCR steps. E. coli strain XL-1 Blue
(Stratagene) was used in all recombinant DNA manipulations, while the
Met-auxotrophM15MA (19) carrying the plasmid pREP4 (Qiagen) was used as
the expression host, unless noted otherwise. All DNA sequencing was per-
formed by Laragen Inc. or by the Caltech DNA sequencing facility. Plasmids
pAJL-20 and pAJL-61 (21) were used in cell-surface labeling and mDHFR
expression, respectively. Both plasmids carry a cassette encoding amonomeric
version of E. coli MetRS truncated at residue 548 (36) under control of its
natural promoter. In addition, pAJL-20 encodes a variant of E. coliOmpC that
carries six surface-exposed Met residues (19), while pAJL-61 directs the syn-
thesis of an N-terminally 6His-tagged mDHFR, both under control of the
IPTG-inducible T5 promoter. Plasmid pMTY21 (34) encodes an N-terminally
6His-tagged MetRS regulated by the T5 promoter for expression and puri-
fication of MetRS mutants and was constructed by ligation of BamHI/SalI-
digested pQE-80L (Qiagen) with a similarly digested MetRS gene PCR-
amplified from pAJL-20 or pAJL-61 using the primers MRS_BamHI and
MRS_SalI-r. Sequences for all primers used in this study are listed in Table S3.
Nomenclature for plasmids modified to carry MetRS mutants is explained in
the SI Text.
MetRS Library Construction.Oligonucleotides encoding degenerate NNK (N
A, T, G, C; K  G, T) codons at sites corresponding to Leu-13, Tyr-260, and
His-301 in E. coli MetRS were obtained from Operon. Four separate PCR
reactions were performed using PfuUltra HighFidelity polymerase (Strat-
agene), pAJL-20 as a template and the following primer pairs: lib_fwd2/
L13_lib2-r, L13_lib3/Y260_lib3-r, Y260_lib3/H301_lib3-r, and H301_lib2/
lib_rev2. The DNA fragments obtained were isolated by electrophoresis and
desalted on Zymo-spin columns (Zymo Research Corp.). Approximately
equimolar quantities of the fragments were mixed and subjected to 20–30
rounds of PCR (95 °C for 30 s, 58 °C for 30 s, 72 °C for 2 min). To amplify the
assembled product, the primers lib_fwd3 and lib_rev3 were added to the
reaction mixture and 20–30 more rounds of PCR were performed using the
same conditions. The resulting 2.0 kb PCR product was digestedwithNotI and
BsrGI to reveal a 1.35-kb insert, which was subsequently ligated using an
insert/vector molar ratio of 3:2 into pAJL-20 digested with the same enzymes.
Minimizing UV-exposure during DNA manipulations was found to be critical
for high ligation efficiency. Resulting plasmids were electroporated into
ElectroTen (Stratagene) cells yielding 4.5  107 independent transformants.
The plasmids from pooled transformants were isolated on Miniprep columns
(Qiagen) and electroporated into M15MA[pREP4] to yield 1.3 107 indepen-
dent clones. Aliquots of the cultures containing the library (1 ml, OD600 1.0)
were stored at 80 °C in 50% glycerol until protein expression.
OmpC Expression and Cell-Surface Labeling. Expression of the OmpC mutant
carrying Anl was performed as described in ref. 21 with minor modifications.
M15MA[pREP4/pAJL-20] cells were inoculated into M9 medium (M9 salts,
0.2%glucose, 1mMMgSO4, 25mg/L thiamine) supplementedwith 40mg/L of
each of the 20 canonical amino acids, 200 mg/L ampicillin, and 35 mg/L
kanamycin (referred to as M9 20aa) either 1:100 from overnight cultures or
1:30 from frozen stocks carrying theMetRS library. After reachingOD600 0.8
to 1.0, cells were pelleted at 5,000 g for 7 min and resuspended in an equal
volume of M9 medium supplemented with 19 amino acids (no Met) and
antibiotics (referred to as M9  19aa). After cells were incubated while
shaking for 15min at 37 °C to deplete any residualMet, theyweremoved into
fresh M9  19aa medium, divided into multiple vessels, and supplemented
with Met or Anl (commonly introduced at 0.3 mM and 1.0 mM, respectively),
or noMet surrogate. Expression of OmpC was initiated by addition of IPTG (1
mM); after 30–40 min a 1-mL aliquot of each culture adjusted to OD600 1.0
was washed with PBS (PBS, pH 7.4) in preparation for cell-surface labeling.
After OmpC expression, cells were treated with 100 M biotin-PEO-
cyclooctyne with agitation for 16 h at 37 °C. Biotin-labeled cells were cooled
to 4 °C, washed twice with 1-mL PBS, and treated with 2.5 L of a 1-mg/mL
solution of avidin-Alexa Fluor 488 conjugate (Molecular Probes) for 2 h at 4 °C
with agitation. Cellswerewashed threemore timeswith PBS to remove excess
fluorophore and labeling was confirmed on a Safire II (Tecan) plate reader or
by flow cytometry.
To determine the number of viable cells after OmpC expression and label-
ing, the cell density was adjusted to OD600  0.2. Cells were further diluted
1:104 and 1:2.5 105 into PBS, and 100 L from each dilution was plated onto
2YT agar supplemented with 200-mg/L ampicillin and 35-mg/L kanamycin.
The number of colonies on each plate was determined after overnight incu-
bation at 37 °C.
Flow Cytometry and Cell Sorting. All flow cytometric analyses were performed
on a MoFlo (DakoCytomation) FACS equipped with an argon ion laser emit-
tingat 488nm.Thenaïve librarywas sorted in the ‘‘sort purify’’mode,whereas
for all subsequent sorts the ‘‘sort single’’ mode was used. Sort gates were set
and data analysis was performed with Summit software (DakoCytomation).
After cell-surface labeling, highly fluorescent cells were isolated by setting
gates in the fluorescence channel for the top 0.8% to 1.2%of the population.
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Additional gates were set in the forward- and side-scatter channels to avoid
events of unusual size. Thegateon thefluorescence channelwas set especially
high (0.5%) for libraries expressing OmpC at low concentrations of Anl. In a
typical experiment, 108 eventswere interrogated, ofwhich 5105were taken
to the following round. Sorted cells were rescued in 15mL of SOCmedium for
30 min before antibiotics were added (200 mg/L ampicillin, 35 mg/L kanamy-
cin). An aliquot of rescued cells was plated on selective 2YT agar plates for
analysis of individual clones. Cultures adjusted to OD600  1.0 were either
stored at 80 °C in 50% glycerol or immediately carried through to the next
round of selection.
The dose–response relationship between Anl concentration in expression
media and fluorescence observed on FACS after cell-surface labeling was
determined on M15MA[pREP4/pAJL-20] cells as described above. OmpC ex-
pressionwas induced inM9 19aamedium supplementedwith 0.03, 0.1, 0.3,
1.0, and 3.0 mM Anl. After cell-surface labeling, the median population
fluorescence was determined based on FACS data. EC50 values were obtained
by performing a least-squares fit to the Hill equation using KaleidaGraph
(v3.6; Synergy Software).
Recombinant DHFR Expression, Purification, and Analysis. Expression of Anl-
bearing mDHFR was performed in M15MA[pREP4/pAJL-61] cells, using the
same protocol for OmpC expression, but inducing expression for 3.5 h with
IPTG. Variants of the pAJL-61 plasmid carrying different MetRS mutants were
generated using QuikChange site-directed mutagenesis (primers listed in
Table S3). Integrity of all constructs was verified by DNA sequencing. Protein
was expressed in 5–10mL cultures, aliquots standardized forOD600were saved
for SDS/PAGE analysis, and the remainder was lysed in 8 M urea. Purification
wasperformedunderdenaturing conditionsonNi-NTA spin columns (Qiagen)
according to the manufacturer’s suggestions. For MALDI-MS analysis, 15-L
purified mDHFR was diluted with 95 L of 75 mM NH4HCO3 and digested for
4 h at 37 °C with 0.2 g of porcine trypsin (Promega). The resulting peptide
mixtures were desalted on C18 ZipTip (Millipore) columns. Eluents were
diluted 3-fold with matrix solution [saturated -cyano hydroxycinnamic acid
(Fluka) in 1:1 water/acetonitrile and 0.1% trifluoroacetic acid] and analyzed
on a Voyager MALDI-TOF mass spectrometer (Applied Biosystems).
MetRS Expression, Purification, and in Vitro Activation Assays. Variants of
pMTY21 carryingdifferentMetRSmutantswere constructed either by the PCR
amplification and ligation into pMTY21 of MetRS from pAJL-20 or pAJL-61 or
by QuikChange site-directedmutagenesis as discussed above. E. coliXL-1 Blue
cells transformed with pMTY21 were inoculated 1:100 from an overnight
culture into 100mL of Terrific Broth. Cells were grown to OD600 1.0 at 37 °C
and were induced with IPTG (1 mM) to produce MetRS for 18 h at 25 °C. Cells
were harvested by centrifugation (6,000 g for 15min). 6His-taggedMetRS
mutants were isolated under native conditions on Ni-NTA agarose resin
(Qiagen) according to the manufacturer’s instructions. Eluted product was
exchanged into 100mMTris buffer (pH 7.5 with 2mMDTT) on PD-10 columns
(GE Healthcare). Enzyme stocks were prepared in 50% (wt/wt) glycerol and
stored at 80 °C until needed. Enzyme concentrations were determined
based on the absorbance at 280 nm of the enzyme stock diluted 1:9 in 9 M
urea, and assuming an extinction coefficient of 93,280 M1 cm1 for MetRS
mutants as calculated by the ProtParam tool (http://expasy.org/tools/
protparam.html). Amino acid activation assays were carried out as described
in ref. 37. Radiolabeled sodium 32P-pyrophosphate was purchased from Per-
kin-Elmer Life Sciences. An enzyme concentration in the range 1–4 M was
used in each reaction, and activation rates were measured at 0.031–16 mM
Met and 0.25–64 mMAnl. Kinetic parameters were determined by fitting the
initial activation rates to the Michaelis-Menten model using KaleidaGraph
(v3.6; Synergy Software).
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